Tirzepatide in PWS, HO and GNSO

Clinical trial NCT06901245 · RECRUITING

Trial details

NCT number: NCT06901245
Sponsor: Grace Kim
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Prader-Willi Syndrome Hypothalamic Obesity Obesity/Therapy

Start date: 2025-05-01
Primary completion: 2026-06-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.